A new oral HER2-directed breast cancer therapy from Bayer AG, and its companion diagnostic from Thermo Fisher Scientific Inc., have been approved by the U.S. FDA. Hyrnuo (sevabertinib), a reversible ...

Abbott Laboratories made plans to enter the cancer screening market with its reported acquisition of Exact Sciences Corp. The ...

Could GLP-1 receptor agonists (GLP-1RAs), already used in obesity and diabetes, be repurposed as drugs to slow aging? Hong ...

Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...

Agios Pharmaceuticals Inc. reported top-line data from its 52-week Rise Up trial testing oral pyruvate kinase activator mitapivat in sickle cell disease (SCD), which hit statistical significance on ...

At the 2025 annual meeting of the Society for Neuroscience in San Diego this week, Catherine Woolley’s plenary lecture was an ...

Harbour Biomed is stepping up its antibody discovery process by using AI to develop innovative therapeutics. “We have done ...

Tempest Therapeutics Inc. entered definitive agreements approved by its board to acquire certain dual-targeting CAR T ...

In a verbal sparring over who can deliver the lowest drug prices in the U.S., several Senate Democrats are urging President ...

Success in Japan may further bolster Protara Therapeutics Inc. in its push with TARA-002 in pediatric patients with ...

The limited efficacy of cancer immunotherapy is usually attributed to suboptimal antitumor T-cell generation, as well as ...

Radiopharm Theranostics Ltd. has been granted Bellberry Human Research Ethics Committee (HREC) approval in Australia to ...